Long before “peptide” became a wellness buzzword, your body was the expert. Insulin, ghrelin, oxytocin, GLP-1, BDNF, the natriuretic peptides that help regulate blood pressure. All of them are peptides: short chains of amino acids your own cells assemble, cut to size, finish and release on schedule, every day of your life. Each step of that assembly line is written in DNA, which means parts of it are readable in an ordinary raw data file.
An assembly line, not a single gene
A peptide hormone starts as a longer precursor protein encoded by a gene. Enzymes then do the manufacturing: prohormone convertases such as PC1/3 (the PCSK1 gene) cut the precursor at precise points, and finishing enzymes such as PAM put the final chemical touches on many peptides so they become active. The signal only lands if a receptor, itself encoded by a gene such as GLP1R for GLP-1, is there to receive it. Genetic variation can sit at any station: the peptide’s own sequence, the cutting, the finishing, or the receiving end.
Three examples worth knowing
A peptide that comes out longer. ANP, made by the heart, helps the body shed sodium and relax blood vessels. One known variant in its gene changes the stop signal, so carriers make a version two amino acids longer. Association studies have linked the variant to differences in cardiovascular outcomes. These are associations in studied groups, not a diagnosis in any individual, but a vivid example of a peptide’s actual shape varying between healthy people.
A peptide that’s packaged differently. BDNF supports the growth and connection of neurons, and its Val66Met variant is one of the most studied letters in neuroscience. Cell experiments show the Met version changes how the precursor is packaged and released inside neurons; its links to memory measures in people have been studied for two decades and remain genuinely debated. An honest reading reports the solid cell biology and the unsettled rest, in that order.
Peptides carried along the maternal line. Some of the newest entries in this field are microproteins encoded inside mitochondrial DNA, tiny peptides like SHMOOSE, described in 2022 and studied in brain metabolism. Because mitochondria pass from mother to child, these versions travel along the maternal line, a different kind of inheritance than the rest of your file.
The receiving end varies too: common variants in the GLP-1 and GIP receptor genes, the gut-hormone receptors, are an active research frontier, including a large 2026 study in Nature built on 23andMe participants.
What a file can say, and what it never can
A raw DNA file can report which version of a peptide gene, processing enzyme or receptor you carry, wherever your chip actually read that position. It cannot measure how much of any peptide is circulating in your blood today. That is a laboratory measurement, not a genotype, and it does not tell anyone to take anything. The peptides in this article are ones your body makes itself; questions about any substance or medication belong with a clinician, full stop.
Evigenics’ new Peptide genes report reads twelve markers across this assembly line (peptides, processing enzymes, receptors and the maternal-line microproteins), each with its evidence, its population context and its misses stated plainly. If this layer of your biology is new to you, start with what raw DNA interpretation can and cannot tell you, then look at what your own file covers.